WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
明确的多功能聚合物纳米载体可实现有效的基因传递
基本信息
- 批准号:8085835
- 负责人:
- 金额:$ 27.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:BiologicalBloodBuffersCell CycleCell NucleusCell modelCellsCharacteristicsChargeChemistryClinical TrialsComplexCustomCytosolDNADevelopmentDissociationDrug FormulationsEffectivenessElectrostaticsEndocytosisEndosomesEnvironmentEvaluationFamilyFutureGene DeliveryGene ExpressionGenesGoalsGrowthGuidelinesHepatocyteIn VitroInjection of therapeutic agentInterphase CellInvestigationLeftLigandsLinkLiverLiver diseasesLysosomesMembraneMethodsModelingMutationNatureNon-Viral VectorNuclearNuclear EnvelopeNuclear ImportNuclear PoreOrganOutputPerformancePharmacologic SubstancePhasePolymersPreparationProcessProductionProliferatingProtonsRelative (related person)ResearchRoleSerumSerum ProteinsSiteSolubilityStreamSulfonamidesSurfaceSystemTestingTimeToxic effectTransfectionViralViral VectorWorkaqueousbasecell growthcontrolled releasecytotoxicitydesignextracellularflexibilityfunctional groupgene therapygene therapy clinical trialin vivonanocarriernanoscalenanosizednovelnovel strategiesnucleocytoplasmic transportpolyanionpolycationpublic health relevancereceptortooltraffickingtranslational studytumorvectorviral gene delivery
项目摘要
DESCRIPTION (provided by applicant): Despite several advantages of non-viral vectors over viral vectors in gene therapy, few clinical trials have investigated non-viral systems. A major reason for the suboptimal performance of non-viral gene approaches is their low transfection efficiency especially in vivo. Extensive investigations into the major limiting factors during the cellular trafficking processes have provided spectra of tools anticipated to circumvent the extracellular and intracellular obstacles in successful use of non-viral systems. Polymeric vectors demonstrate great flexibility in their design and functionalization. Biodegradable or non-degradable polycations are often used as DNA condensing vectors and modifying a few functional groups helps targeting and trafficking into the nucleus. However, current approaches are not truly well-defined because the modified polycations are electrostatically and randomly complexed with anionic genes. A poorly defined vector preparation with a few functionalities and inadequate exposure of the functional groups at the right places are primarily responsible for low efficiency. A novel approach proposed in this application is to accommodate all functionalities (as many as needed) for gene trafficking from an injection site to the nucleus, which include shielding the positively charged surface in the blood stream, cell targeting ligands, endosomolytic agents, controlled release of DNA from polyplex, nuclear pore dilation and nuclear import. All these functionalities will be incorporated into nanoscaled assemblies constructed by a layer-by-layer method, resulting in triple layered gene vectors; the core, mantle, and the shell layers. More importantly the nanoconstruct is expected to expose the functional groups at the place required in the intracellular compartments in a well defined manner and each layer will be peeled-off after serving its due role, leaving minimal components for nuclear import of the incorporated gene. This unique assembly approach assures high potential for pharmaceutical gene formulations for future translational studies. The long term goal will be accomplished in four specific aims: first three aims for core layer, mantle layer and shell layer respectively. Each layer will be customized for target cells; proliferating and non-proliferating cells, endosomal pH, and ligand receptor. The fourth specific aim will test and prove the proposed concept in vivo.
PUBLIC HEALTH RELEVANCE: Despite several advantages of non-viral vectors over viral owns in gene therapy, particularly in reproducible production of pharmaceutical formulations, most clinical trials for gene therapy employed viral systems. This application is for development of polymeric gene carriers based on a new design concept, which is anticipated to present a high potential for a translational study, for acceptable transfection efficiency in vivo and have minimal toxicity. The novel and unique design principle will accommodate all functionalities required for effective gene transfection and these functionalities will be exposed in the appropriate intracellular compartments where needed the most in a well-defined fashion. The nano-sized gene carrier will be constructed from pharmaceutically-friendly polymers.
描述(由申请人提供):尽管在基因治疗中非病毒载体比病毒载体有一些优势,但很少有临床试验研究非病毒系统。非病毒基因方法表现不佳的一个主要原因是它们的转染效率低,特别是在体内。对细胞运输过程中主要限制因素的广泛调查提供了一系列工具,有望在成功使用非病毒系统时绕过细胞外和细胞内障碍。高分子载体在设计和功能化方面表现出极大的灵活性。可生物降解或不可降解的聚阳离子通常用作DNA浓缩载体,修饰一些官能团有助于靶向和运输到细胞核。然而,目前的方法并没有真正定义好,因为修饰的聚阳离子是静电的,并且随机地与阴离子基因络合。载体制备的定义不明确,功能很少,在适当的地方暴露的官能团不足,是导致效率低的主要原因。本应用中提出的一种新方法是适应从注射部位到细胞核的基因运输的所有功能(尽可能多),包括在血流中屏蔽带正电荷的表面,细胞靶向配体,内溶剂,从复合体中控制DNA释放,核孔扩张和核输入。所有这些功能将被纳入纳米级组装通过一层一层的方法,导致三层基因载体;地核,地幔和地壳层。更重要的是,纳米结构有望以明确的方式将功能基团暴露在细胞内区室所需的位置,每一层在发挥其应有的作用后将被剥离,留下最小的成分用于整合基因的核输入。这种独特的组装方法确保了未来翻译研究的药物基因配方的高潜力。长期目标将在四个具体目标上实现:前三个目标分别为核心层、地幔层和壳层。每一层将为目标细胞定制;增殖和非增殖细胞,内体pH值和配体受体。第四个具体目标将在体内测试和证明所提出的概念。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
You Han Bae其他文献
“On–Off“ Thermocontrol of Solute Transport. II. Solute Release from Thermosensitive Hydrogels
- DOI:
10.1023/a:1015860824953 - 发表时间:
1991-01-01 - 期刊:
- 影响因子:4.300
- 作者:
You Han Bae;Teruo Okano;Sung Wan Kirn - 通讯作者:
Sung Wan Kirn
Cancer targeting paradigm: does it need to be shifted?
- DOI:
10.1016/j.nano.2007.10.041 - 发表时间:
2007-12-01 - 期刊:
- 影响因子:
- 作者:
You Han Bae - 通讯作者:
You Han Bae
Low‐temperature processable biodegradable block copolymers embedded with proteins
嵌入蛋白质的可低温加工的可生物降解的嵌段共聚物
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Yu Matsumoto;Joseph W. Nichols;Kazuko Toh;Takahiro Nomoto;Horacio Cabral;Yutaka Miura;R. James Christie;Naoki Yamada;Tadayoshi Ogura;Mitsunobu R. Kano;Yasuhiro Matsumura;Nobuhiro Nishiyama;Tatsuya Yamasoba;You Han Bae;Kazunori Kataoka;Yasuhiko Iwasaki - 通讯作者:
Yasuhiko Iwasaki
“On–Off” Thermocontrol of Solute Transport. I. Temperature Dependence of Swelling of N-Isopropylacrylamide Networks Modified with Hydrophobic Components in Water
- DOI:
10.1023/a:1015871732706 - 发表时间:
1991-01-01 - 期刊:
- 影响因子:4.300
- 作者:
You Han Bae;Teruo Okano;Sung Wan Kim - 通讯作者:
Sung Wan Kim
Hydrogels: Swelling, Drug Loading, and Release
- DOI:
10.1023/a:1015887213431 - 发表时间:
1992-01-01 - 期刊:
- 影响因子:4.300
- 作者:
Sung Wan Kim;You Han Bae;Teruo Okano - 通讯作者:
Teruo Okano
You Han Bae的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('You Han Bae', 18)}}的其他基金
WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
明确的多功能聚合物纳米载体可实现有效的基因传递
- 批准号:
8257580 - 财政年份:2009
- 资助金额:
$ 27.51万 - 项目类别:
WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
明确的多功能聚合物纳米载体可实现有效的基因传递
- 批准号:
7817124 - 财政年份:2009
- 资助金额:
$ 27.51万 - 项目类别:
Intelligent Polymeric Nanogel Technology Overcoming Drug Resistance in Ovarian Ca
智能聚合物纳米凝胶技术克服卵巢钙耐药性
- 批准号:
7696849 - 财政年份:2009
- 资助金额:
$ 27.51万 - 项目类别:
Micelle surface engineering for active targeting by acidic tumor extracellular pH
胶束表面工程通过酸性肿瘤细胞外 pH 值主动靶向
- 批准号:
7130778 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
A novel approach for long term protein delivery
一种长期蛋白质输送的新方法
- 批准号:
7141503 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
A novel approach for long term protein delivery
一种长期蛋白质输送的新方法
- 批准号:
7664879 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
Micelle surface engineering for active targeting by acidic tumor extracellular pH
胶束表面工程通过酸性肿瘤细胞外 pH 值主动靶向
- 批准号:
7279446 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
A novel approach for long term protein delivery
一种长期蛋白质输送的新方法
- 批准号:
7269465 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
Micelle surface engineering for active targeting by acidic tumor extracellular pH
胶束表面工程通过酸性肿瘤细胞外 pH 值主动靶向
- 批准号:
7893033 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
A novel approach for long term protein delivery
一种长期蛋白质输送的新方法
- 批准号:
7472401 - 财政年份:2006
- 资助金额:
$ 27.51万 - 项目类别:
相似海外基金
経胸壁心臓超音波のBlood Speckle Imagingを用いた大動脈弓部病変評価の研究
经胸心脏超声血斑成像评价主动脉弓病变的研究
- 批准号:
24K10591 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A cluster randomized controlled trial to evaluate pharmacy-based health promotion program to improve blood pressure control in Bangladesh, India and Pakistan
一项整群随机对照试验,旨在评估孟加拉国、印度和巴基斯坦基于药房的健康促进计划,以改善血压控制
- 批准号:
23K24566 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Open Access Block Award 2024 - NHS Blood and Transplant NHSBT School
2024 年开放获取块奖 - NHS 血液和移植 NHSBT 学校
- 批准号:
EP/Z532551/1 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Research Grant
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Fellowship
A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
- 批准号:
24K15741 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
STTR Phase I: A Completely Non-Toxic Blood Bag That Keeps Blood Healthier, Longer
STTR 第一阶段:完全无毒的血袋,使血液保持更健康、更长久
- 批准号:
2335363 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Standard Grant
How blood vessel stiffness regulates their growth and maintenance
血管硬度如何调节其生长和维持
- 批准号:
DE240101055 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Discovery Early Career Researcher Award
Engaging the over 50s to ensure the sustainability of our blood supply
让 50 多岁的人参与进来,确保我们血液供应的可持续性
- 批准号:
LP220200819 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Linkage Projects
Applying a Program Science approach for strengthening partnerships and advancing embedded research to optimize public health programming for HIV and sexually transmitted and blood-borne infections among criminalized populations in the Global South
应用计划科学方法来加强伙伴关系并推进嵌入式研究,以优化南半球犯罪人群中针对艾滋病毒、性传播和血源性感染的公共卫生规划
- 批准号:
502554 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Designing and fabricating artificial blood cells for global shortages
设计和制造人造血细胞应对全球短缺
- 批准号:
DE240100236 - 财政年份:2024
- 资助金额:
$ 27.51万 - 项目类别:
Discovery Early Career Researcher Award